About Compass Therapeutics
We are developing next-generation antibodies into transformative cancer therapies that improve patients’ lives.
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Boston, MA
- Founded
- 2014
- Company type
- Public Company
- Company profile name
- Compass Therapeutics Inc.
Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass’ scientific focus is on the relationship between angiogenesis, the immune system and tumor growth. The company pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The company was founded in 2014 and is headquartered in Boston, Massachusetts.
To learn more, visit www.compasstherapeutics.com
Specialties
- Drug Discovery and Development
- Biologics
- Oncology
- and Immuno-Oncology
Company locations
80 Guest Street, Suite 601, Boston, MA 02135, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
On LinkedIn
- Followers
- 11,209
- People linked to this company
- 62
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.